As described above, we found that spike-specific CXCR3+ TFH cells were associated with antibody response magnitude and were more responsive than spike-specific CXCR3− TFH cells upon antigen stimulation in both COVID-19 convalescents and vaccinees (Figs. 1–6). The gene discussed is CXCR3; the disease is COVID-19.